CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer
Transl Cancer Res
.
2020 Apr;9(4):2168-2170.
doi: 10.21037/tcr.2020.03.09.
Authors
Jordi Remon
1
,
Ana Collazo
2
,
Beatriz Jimenez
2
Affiliations
1
Department of Medical Oncology, Centro Integral Oncológico Clara Campal (HM-CIOCC), Hospital HM Delfos, HM Hospitales, Barcelona, Spain.
2
Centro Integral Oncología Clara Campal Madrid, HM-Sanchinarro, Medical Oncology Department, Madrid, Spain.
PMID:
35117575
PMCID:
PMC8797323
DOI:
10.21037/tcr.2020.03.09
No abstract available
Publication types
Editorial
Comment